Associations and prognostic interactions between circulating levels of hepcidin, ferritin and inflammatory cytokines in primary myelofibrosis

Second round robin for plasma hepcidin methods: First steps toward harmonization

(2012) Joyce J.C. Kroot et al.   AMERICAN JOURNAL OF HEMATOLOGY

One Thousand Patients With Primary Myelofibrosis: The Mayo Clinic Experience

(2012) Ayalew Tefferi et al.   MAYO CLINIC PROCEEDINGS

Iron overload and iron chelation therapy in patients with myelodysplastic syndrome treated by allogeneic stem-cell transplantation: Report from the working conference on iron chelation of the Gruppo Italiano Trapianto di Midollo Osseo

(2011) Emilio Paolo Alessandrino et al.   AMERICAN JOURNAL OF HEMATOLOGY

Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation

(2011) Chia Chi Sun et al.   AMERICAN JOURNAL OF HEMATOLOGY

Hepcidin and iron regulation, 10 years later

(2011) T. Ganz   BLOOD

Hepcidin expression in patients with acute leukaemia

(2011) Pan-Pan Cheng et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study

(2011) Ayalew Tefferi et al.   JOURNAL OF CLINICAL ONCOLOGY

Hepcidin Levels and Their Determinants in Different Types of Myelodysplastic Syndromes

(2011) Valeria Santini et al.   PLoS One

Two to Tango: Regulation of Mammalian Iron Metabolism

(2010) Matthias W. Hentze et al.   CELL

Hepcidin expression in anemia of chronic disease and concomitant iron-deficiency anemia

(2010) Pan-pan Cheng et al.   CLINICAL AND EXPERIMENTAL MEDICINE

DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status

(2010) Naseema Gangat et al.   JOURNAL OF CLINICAL ONCOLOGY

Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients

(2010) D Caramazza et al.   LEUKEMIA

Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis

(2010) Srdan Verstovsek et al.   NEW ENGLAND JOURNAL OF MEDICINE

Objectives of iron chelation therapy in myelodysplastic syndromes: more than meets the eye?

(2009) V. Pullarkat   BLOOD

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

(2009) J. W. Vardiman et al.   BLOOD

Urinary hepcidin excretion in patients with myelodysplastic syndrome and myelofibrosis

(2008) Asher Winder et al.   BRITISH JOURNAL OF HAEMATOLOGY